Correlation Between Mineralys Therapeutics, and Cadrenal Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Cadrenal Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Cadrenal Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Cadrenal Therapeutics, Common, you can compare the effects of market volatilities on Mineralys Therapeutics, and Cadrenal Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Cadrenal Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Cadrenal Therapeutics,.

Diversification Opportunities for Mineralys Therapeutics, and Cadrenal Therapeutics,

-0.08

Correlation Coefficient

Mineralys Therapeutics,  Cadrenal Therapeutics,

Good diversification

The 3 months correlation between Mineralys and Cadrenal is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Cadrenal Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cadrenal Therapeutics, and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Cadrenal Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cadrenal Therapeutics, has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Cadrenal Therapeutics, go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Cadrenal Therapeutics,

Given the investment horizon of 90 days Mineralys Therapeutics, is expected to generate 1.05 times less return on investment than Cadrenal Therapeutics,. In addition to that, Mineralys Therapeutics, is 1.65 times more volatile than Cadrenal Therapeutics, Common. It trades about 0.07 of its total potential returns per unit of risk. Cadrenal Therapeutics, Common is currently generating about 0.12 per unit of volatility. If you would invest  1,423  in Cadrenal Therapeutics, Common on December 30, 2024 and sell it today you would earn a total of  423.00  from holding Cadrenal Therapeutics, Common or generate 29.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Cadrenal Therapeutics, Common

Mineralys Therapeutics,

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Mineralys Therapeutics, unveiled solid returns over the last few months and may actually be approaching a breakup point.

Cadrenal Therapeutics,

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cadrenal Therapeutics, Common are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward-looking signals, Cadrenal Therapeutics, exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mineralys Therapeutics, and Cadrenal Therapeutics,

The main advantage of trading using opposite Mineralys Therapeutics, and Cadrenal Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Cadrenal Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cadrenal Therapeutics, will offset losses from the drop in Cadrenal Therapeutics,'s long position.

The idea behind Mineralys Therapeutics, Common and Cadrenal Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.